Company News: Page (1) of 1 - 02/05/13 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

Cerner Reports Fourth Quarter 2012 Results

(February 05, 2013)

KANSAS CITY, Mo., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq:CERN) today announced results for the 2012 fourth quarter and full year that ended December 29, 2012, delivering strong levels of bookings, revenue, earnings and cash flow.



Bookings in the fourth quarter of 2012 were $1.02 billion, an all-time high and an increase of 13 percent compared to fourth quarter 2011 bookings of $899.0 million. Full year 2012 bookings were a record $3.14 billion, up 15 percent compared to 2011 bookings of $2.72 billion.



Fourth quarter revenue was a record $710.4 million, an increase of 15 percent compared to $615.6 million in the year-ago period. Full year 2012 revenue was $2.67 billion, up 21 percent compared to 2011 revenue of $2.20 billion.


On a U.S. Generally Accepted Accounting Principles (GAAP) basis, fourth quarter 2012 net earnings were $111.8 million and diluted earnings per share were $0.63. Fourth quarter 2011 GAAP net earnings were $91.2 million and diluted earnings per share were $0.52. For the full year, 2012 GAAP net earnings were $397.2 million and diluted earnings per share were $2.26. Full year 2011 GAAP net earnings were $306.6 million and diluted earnings per share were $1.76.




Adjusted (non-GAAP) Net Earnings



Adjusted net earnings for fourth quarter 2012 were $118.2 million, an increase of 23 percent compared to $96.2 million of adjusted net earnings in the fourth quarter of 2011. Adjusted diluted earnings per share were $0.67 in the fourth quarter of 2012 compared to $0.55 of adjusted diluted earnings per share in the year-ago quarter. Analysts' consensus estimate for fourth quarter 2012 adjusted diluted earnings per share was $0.64. For the full year 2012, adjusted net earnings were $420.8 million and adjusted diluted earnings per share were $2.39, compared to full year 2011 adjusted net earnings of $324.9 million and adjusted diluted earnings per share of $1.87.



Adjusted net earnings is not a recognized term under GAAP and should not be substituted for net earnings as a measure of Cerner's performance but instead should be utilized as a supplemental measure of financial performance in evaluating our business. Following is a description of adjustments made to net earnings. For more detail, please see the accompanying schedule, titled "Reconciliation of GAAP Results to Non-GAAP Results."



Adjusted net earnings and diluted earnings per share exclude share-based compensation expense, which reduced fourth quarter 2012 net earnings and diluted earnings per share by $6.4 million and $0.04, respectively; and reduced fourth quarter 2011 net earnings and diluted earnings per share by $5.0 million and $0.03, respectively. Share based compensation expense reduced full year 2012 net earnings and diluted earnings per share by $23.5 million and $0.13, respectively, and reduced full year 2011 net earnings and diluted earnings per share by $18.2 million and $0.11, respectively.



Other 2012 Fourth Quarter and Full Year Highlights:




  • Fourth quarter cash collections of $689.8 million and operating cash flow of $180.6 million. For the full year, cash collections were $2.71 billion and operating cash flow was $708.3 million.


  • Fourth quarter free cash flow of $99.4 million. For the full year, free cash flow was a record $424.7 million, up 18 percent from $358.6 million in 2011. Free cash flow is a non-GAAP financial measure defined as GAAP cash flows from operating activities less capital purchases and capitalized software development costs. For more detail, please see the accompanying schedule, titled "Reconciliation of GAAP Results to Non-GAAP Results."


  • Fourth quarter days sales outstanding of 74 days, which is down from 83 days in the year-ago quarter.


  • Total backlog of $7.27 billion, up 19 percent over the year-ago quarter. This was comprised of $6.53 billion of contract backlog and $738.2 million of support and maintenance backlog.



"2012 was great year for Cerner. We delivered outstanding bookings, revenue, earnings and cash flow growth, with this growth coming from expanding relationships with existing clients and record levels of bookings from new clients," Neal Patterson, Cerner chairman, CEO, president and co-founder said. "I was also very pleased with our innovation, as we significantly advanced our cloud-based physician solutions and population health capabilities. In 2013, we plan to build on this success and continue to invest heavily in research and development to increase our competitive advantages and position us for strong growth throughout this decade."



Future Period Guidance



Cerner currently expects:




  • First quarter 2013 revenue between $690 million and $715 million.


  • Full year 2013 revenue between $2.95 billion and $3.05 billion.


  • First quarter 2013 adjusted diluted earnings per share before share based compensation expense between $0.61 and $0.63.


  • Full year 2013 adjusted diluted earnings per share before share based compensation expense between $2.75 and $2.82.


  • First quarter 2013 new business bookings between $720 million and $760 million.


  • Share based compensation expense to reduce diluted earnings per share by approximately $0.04 in the first quarter of 2013 and between $0.16 and $0.17 for the year.



Earnings Conference Call



Cerner will host an earnings conference call to provide additional detail on these results at 3:30 p.m. CT on February 5. The dial-in number for the conference call is (617) 597-5311; the passcode is Cerner. Cerner recommends joining the call 15 minutes early for registration. The re-broadcast of the call will be available from 5:30 p.m. CT, February 5 through 11:59 p.m. CT, February 8. The dial-in number for the re-broadcast is (617)-801-6888; the passcode is 92987383.



An audio webcast will be available live and archived on Cerner's website at www.cerner.com under the About Cerner section (click Investor Relations, then Presentations and Webcasts).



About Cerner



Cerner is contributing to the systemic change of health and care delivery. For more than 30 years Cerner has been executing its vision to make health care safer and more efficient. We started with the foundation of digitizing paper processes and now offer the most comprehensive array of information software, professional services, medical device integration, remote hosting and employer health and wellness services. Cerner systems are used by everyone from individual consumers, to single-doctor practices, hospitals, employers and entire countries. Taking what we've learned over more than three decades, Cerner is building on the knowledge that is in the system to support evidence-based clinical decisions, prevent medical errors and empower patients in their care.



Cerner® solutions are licensed by approximately 10,000 facilities around the world, including more than 2,700 hospitals; 4,150 physician practices; 45,000 physicians; 550 ambulatory facilities, such as laboratories, ambulatory centers, behavioral health centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; 45 employer sites and 1,750 retail pharmacies.



Certain trademarks, service marks and logos (collectively, the "Marks") set forth herein are owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. All other non-Cerner Marks are the property of their respective owners. Nasdaq:CERN. For more information about Cerner, please visit www.cerner.com, Twitter, Facebook and YouTube.



This release contains forward-looking statements that involve a number of risks and uncertainties. It is important to note that Cerner's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words "plan", guidance", "expects" or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the possibility of product-related liabilities; potential claims for system errors and warranties; the possibility of interruption at our data centers or client support facilities; our proprietary technology may be subject to claims for infringement or misappropriation of intellectual property rights of others, or may be infringed or misappropriated by others; risks associated with our non-U.S. operations; risks associated with our ability to effectively hedge exposure to fluctuations in foreign currency exchange rates; the potential for tax legislation initiatives that could adversely affect our tax position and/or challenges to our tax positions in the United States and non-U.S. countries; risks associated with our recruitment and retention of key personnel; risks related to our dependence on third party suppliers; risks inherent with business acquisitions; the potential for losses resulting from asset impairment charges; risks associated with uncertainty in global economic conditions; changing political, economic, regulatory and judicial influences; government regulation; significant competition and market changes; variations in our quarterly operating results; potential inconsistencies in our sales forecasts compared to actual sales; volatility in the trading price of our common stock and the timing and volume of market activity; our directors' authority to issue preferred stock and the anti-takeover provisions in our corporate governance documents; and material adverse resolution of legal proceedings. Additional discussion of these and other risks, uncertainties and factors affecting Cerner's business is contained in Cerner's periodic filings with the Securities and Exchange Commission. The reader should not place undue reliance on forward-looking statements, since the statements speak only as of the date that they are made. Cerner undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time.






























































































































































































































































































































































































 

 

 

 

 

CERNER CORPORATION AND SUBSIDIARIES

 

 

 

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

 

 

 

For the three and twelve months ended December 29, 2012 and December 31, 2011

 

 

 

(unaudited)

 

 

 

 

 

 

 

 

 

(In thousands, except per share data)

Three Months Ended

Years Ended

 

2012 (1)

2011 (1)

2012 (1)

2011 (1)

Revenues

 

 

 

 

System sales

 $ 251,759

 $ 220,492

 $ 902,799

 $ 706,714

Support, maintenance and services

 445,098

 383,956

 1,707,329

 1,451,747

Reimbursed travel

 13,527

 11,178

 55,308

 44,692

Total revenues

 710,384

 615,626

 2,665,436

 2,203,153

 

 

 

 

 

Margin

 

 

 

 

System sales

 142,496

 128,185

 475,343

 410,153

Support, maintenance and services

 414,777

 355,395

 1,581,896

 1,351,328

Total margin

 557,273

 483,580

 2,057,239

 1,761,481

 

 

 

 

 

Operating expenses

 

 

 

 

Sales and client service

 274,550

 238,224

 1,020,640

 869,962

Software development

 78,624

 73,323

 301,370

 286,801

General and administrative

 43,655

 34,299

 163,567

 144,920

Total operating expenses

 396,829

 345,846

 1,485,577

 1,301,683

 

 

 

 

 

Operating earnings

 160,444

 137,734

 571,662

 459,798

 

 

 

 

 

Other income, net

 7,257

 2,230

 16,046

 9,896

 

 

 

 

 

Earnings before income taxes

 167,701

 139,964

 587,708

 469,694

Income taxes

 (55,893)

 (48,772)

 (190,476)

 (163,067)

Net earnings

 $ 111,808

 $ 91,192

 $ 397,232

 $ 306,627

 

 

 

 

 

Basic earnings per share

 $ 0.65

 $ 0.54

 $ 2.32

 $ 1.82

 

 

 

 

 

Basic weighted average shares outstanding

 171,744

 169,472

 170,931

 168,634

 

 

 

 

 

Diluted earnings per share

 $ 0.63

 $ 0.52

 $ 2.26

 $ 1.76

 

 

 

 

 

Diluted weighted average shares outstanding

 176,180

 174,488

 175,697

 173,867

 

 

 

 

 

Note 1: Operating expenses for the three and twelve months ended December 29, 2012 and December 31, 2011 include share-based compensation expense. The impact of this expense on net earnings and diluted earnings per share is presented below:

 

 

 

 

 

(In thousands, except per share data)

Three Months Ended

Years Ended

 

2012

2011

2012

2011

 

 

 

 

 

Sales and client service

 $ 5,100

 $ 3,923

 $ 17,316

 $ 13,313

Software development

 2,322

 1,950

 9,217

 8,372

General and administrative

 2,922

 2,162

 11,579

 7,794

Total share-based compensation

 10,344

 8,035

 38,112

 29,479

Amount of related income tax benefit

 (3,957)

 (3,074)

 (14,578)

 (11,256)

Net impact on net earnings

 $ 6,387

 $ 4,961

 $ 23,534

 $ 18,223

 

 

 

 

 

Decrease to diluted earnings per share

 $ 0.04

 $ 0.03

 $ 0.13

 $ 0.11

 

 

 

 

 















































































































































































































































 

 

 

 

 

CERNER CORPORATION AND SUBSIDIARIES

RECONCILIATION OF GAAP RESULTS TO NON-GAAP RESULTS1

For the three and twelve months ended December 29, 2012 and December 31, 2011

(unaudited)

 

 

 

 

 

RECONCILIATION OF ADJUSTED NET EARNINGS TO GAAP NET EARNINGS1

 

 

 

 

 

(In thousands)

Three Months Ended

Years Ended

 

2012

2011

2012

2011

Net Earnings

 

 

 

 

Net earnings (GAAP)

 $ 111,808

 $ 91,192

 $ 397,232

 $ 306,627

Share-based compensation expense

 10,344

 8,035

 38,112

 29,479

Income tax benefit of share-based compensation

 (3,957)

 (3,074)

 (14,578)

 (11,256)

Adjusted net earnings (non-GAAP)2

 $ 118,195

 $ 96,153

 $ 420,766

 $ 324,850

 

 

 

 

 

RECONCILIATION OF ADJUSTED DILUTED EARNINGS PER SHARE TO GAAP DILUTED EARNINGS PER SHARE1

 

 

 

 

 

 

Three Months Ended

Years Ended

 

2012

2011

2012

2011

Diluted Earnings Per Share

 

 

 

 

Diluted earnings per share (GAAP)

 $ 0.63

 $ 0.52

 $ 2.26

 $ 1.76

Share-based compensation expense (net of tax)

 0.04

 0.03

 0.13

 0.11

Adjusted diluted earnings per share (non-GAAP)2

 $ 0.67

 $ 0.55

 $ 2.39

 $ 1.87

 

 

 

 

 

RECONCILIATION OF NON-GAAP FREE CASH FLOW TO GAAP OPERATING CASH FLOW1

 

 

 

 

 

(In thousands)

Three Months Ended

Years Ended

 

2012

2011

2012

2011

Cash flows from operating activities (GAAP)

 $ 180,554

 $ 168,489

 $ 708,314

 $ 546,294

Capital purchases

 (53,463)

 (29,193)

 (183,429)

 (104,795)

Capitalized software development costs

 (27,683)

 (21,115)

 (100,189)

 (82,942)

Free cash flow (non-GAAP)3

 $ 99,408

 $ 118,181

 $ 424,696

 $ 358,557

 

 

 

 

 

Note 1: The presentation of Adjusted Diluted Earnings per Share, Adjusted Net Earnings and Free Cash Flow, non-GAAP financial measures, are not meant to be considered in isolation, nor as a substitute for, or superior to, Generally Accepted Accounting Principles (GAAP) results and investors should be aware that non-GAAP measures have inherent limitations and should be read only in conjunction with Cerner's consolidated financial statements prepared in accordance with GAAP. Adjusted Diluted Earnings per Share, Adjusted Net Earnings and Free Cash Flow may also be different from similar non-GAAP financial measures used by other companies and may not be comparable to similarly titled captions of other companies due to potential inconsistencies in the method of calculations. We believe that Adjusted Diluted Earnings per Share, Adjusted Net Earnings and Free Cash Flow are important to enable investors to better understand and evaluate our ongoing operating results and allows for more comprehensive review and understanding of our overall financial, operational and economic performance.

 

 

 

 

 

Note 2: Cerner provides earnings with and without share-based compensation expense because earnings excluding this expense is used by management along with GAAP results to analyze its business, make strategic decisions and for management compensation purposes.

 

 

 

 

 

Note 3: Cerner provides free cash flow because it takes into account the capital expenditures necessary to operate our business.

 

 

 

 

 



















































































































































































































































 

 

 

CERNER CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

As of December 29, 2012 (unaudited) and December 31, 2011

 

 

(In thousands)

2012

2011

 

 

 

Assets

 

 

Current assets:

 

 

Cash and cash equivalents

 $ 317,120

 $ 243,146

Short-term investments

 719,665

 531,635

Receivables, net

 577,848

 563,209

Inventory

 23,681

 23,296

Prepaid expenses and other

 113,572

 94,232

Deferred income taxes, net

 38,620

 46,795

Total current assets

 1,790,506

 1,502,313

 

 

 

Property and equipment, net

 569,708

 488,996

Software development costs, net

 267,307

 248,750

Goodwill

 247,616

 211,826

Intangible assets, net

 132,045

 75,366

Long-term investments

 509,467

 359,324

Other assets

 187,819

 113,783

Total assets

 $ 3,704,468

 $ 3,000,358

 

 

 

Liabilities and Shareholders' Equity

 

 

Current liabilities:

 

 

Accounts payable

 $ 141,212

 $ 85,545

Current installments of long-term debt and capital lease obligations

 59,582

 39,722

Deferred revenue

 189,652

 153,139

Accrued payroll and tax withholdings

 125,253

 109,227

Other accrued expenses

 64,413

 51,087

Total current liabilities

 580,112

 438,720

 

 

 

Long-term debt and capital lease obligations

 136,557

 86,821

Deferred income taxes and other liabilities

 143,212

 150,229

Deferred revenue

 10,937

 13,787

Total liabilities

 870,818

 689,557

 

 

 

Shareholders' Equity:

 

 

Common stock

 1,721

 1,696

Additional paid-in capital

 842,490

 723,490

Retained earnings

 1,994,694

 1,597,462

Accumulated other comprehensive loss, net

 (5,255)

 (11,967)

Total Cerner Corporation shareholders' equity

 2,833,650

 2,310,681

Noncontrolling interest

 -- 

 120

Total shareholders' equity

 2,833,650

 2,310,801

Total liabilities and shareholders' equity

 $ 3,704,468

 $ 3,000,358

 

 

 

CONTACT: Investor Contact:
Allan Kells
(816) 201-2445
akells@cerner.com
Media Contact: Megan Moriarty
(816) 888-2470
megan.moriarty@cerner.com

Cerner's Internet Home Page: www.cerner.com

Page: 1


Related Keywords: EARNINGS, HEALTH, CONFERENCE CALL, WEBCASTPro AV, Post/Production, Management, Presentors, Management, Internet/Web, Business, Internet, Webcasting, Standards/Initiatives, Business Issues, Internet Media, Presentation, Corporate/Company, Events, webcast, USA, Surgery, medical technologists, Surgery, Physician, Science, Financial, Internet Technology, Medical, Computer Science, Business, Internet, Judicial, Other, Medical Professionals,


DMO TEXT LINKS
(Click here to place a textlink on this site)

Vegas Pro 10 Available Now
Professional HD Video, audio, and Blu-Ray creation.
CLICK HERE!!!

HOT THREADS on DMN Forums
Content-type: text/html  Rss  Add to Google Reader or
Homepage    Add to My AOL  Add to Excite MIX  Subscribe in
NewsGator Online 
Real-Time - what users are saying - Right Now!

@ Copyright, 2012 Digital Media Online, All Rights Reserved